Skip to content

Eris Biotech

YC W24 · Active · Our drugs engage the immune system to fight tumors

Competitors

Adjacent

Also from W24

All of W24

About Eris Biotech

We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.

YC batch
W24 · Winter 2024
Status, per YC
Active
Category
Other
Team size
2
Location
Lehi, UT, USA
Checked
34m ago

YC tags: Biotech, Therapeutics, Drug discovery, Oncology

Eris Biotech in W24: 248 companies, 83% AI

Eris Biotech: questions

Which YC batch was Eris Biotech in?

Eris Biotech was in Y Combinator's Winter 2024 batch (W24).

Is Eris Biotech still active?

Y Combinator lists Eris Biotech as active.

Where is Eris Biotech based?

Eris Biotech lists Lehi, UT, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.